Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 6/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.55 |
| ▸ | KCNA5 | P22460 | 4/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.55 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | GRIN2B | Q13224 | 6/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.52 |
| ▸ | GRIN2D | O15399 | 3/20 | 0.52 |
| ▸ | GRIN2A | Q12879 | 3/20 | 0.52 |
| ▸ | GRIN2C | Q14957 | 3/20 | 0.52 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.52 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 5/20 | 0.50 |
| ▸ | HTR2A | P28223 | 5/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.50 |
| ▸ | HTR2B | P41595 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12588287 | 1.00 | CYP2D6 (0.55) | CYP2D6KCNH2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL21093519 | 1.00 | CYP2D6 (0.55) | CYP2D6KCNH2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL21758873 | 0.98 | CYP2D6 (0.54) | CYP2D6KCNH2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2714385 | 0.98 | CYP2D6 (0.54) | CYP2D6KCNH2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2699322 | 0.98 | CYP2D6 (0.54) | CYP2D6KCNH2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2712368 | 0.98 | CYP2D6 (0.54) | CYP2D6KCNH2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL597166 | 0.98 | CYP2D6 (0.54) | CYP2D6KCNH2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL21093474 | 0.98 | CYP2D6 (0.54) | CYP2D6KCNH2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL523547 | 0.98 | CYP2D6 (0.54) | CYP2D6KCNH2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2714074 | 0.98 | CYP2D6 (0.54) | CYP2D6KCNH2CYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2627627-B1 | PROCESS FOR THE SYNTHESIS OF CHIRAL PROPARGYLIC ALCOHOLS | BRISTOL MYERS SQUIBB CO (US) | 2017-08-09 | — | — | EP | claimed |
| EP-2627627-B1 | PROCESS FOR THE SYNTHESIS OF CHIRAL PROPARGYLIC ALCOHOLS | BRISTOL MYERS SQUIBB CO (US) | 2017-08-09 | — | — | EP | disclosed |
| EP-2627643-B1 | PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES | BRISTOL MYERS SQUIBB CO (US) | 2016-11-23 | — | — | EP | disclosed |
| US-20160326101-A1 | Process for the Synthesis of Chiral Propargylic Alcohols | BRISTOL MYERS SQUIBB CO (US) | 2016-11-10 | — | — | US | disclosed |
| US-8969550-B2 | Process for the synthesis of cyclic carbamates | LONZA LTD. (CH) | 2015-03-03 | — | — | US | disclosed |
| US-8957204-B2 | Process for the synthesis of cyclic carbamates | LONZA LTD. (CH) | 2015-02-17 | — | — | US | disclosed |
| EP-2627642-B1 | PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES | LONZA AG (CH) | 2014-12-24 | — | — | EP | disclosed |
| US-20130324763-A1 | PROCESS FOR THE SYNTHESIS OF CHIRAL PROPARGYLIC ALCOHOLS | LONZA LTD (CH) | 2013-12-05 | — | — | US | disclosed |
| US-20130217875-A1 | PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES | LONZA LTD (CH) | 2013-08-22 | — | — | US | disclosed |
| EP-2627642-A1 | PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES | Lonza Ltd (CH) | 2013-08-21 | — | — | EP | disclosed |
| US-20130211077-A1 | PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES | LONZA LTD (CH) | 2013-08-15 | — | — | US | disclosed |
| WO-2012097510-A1 | PROCESS FOR PREPARATION OF EFAVIRENZ BY CYCLISATION | LONZA LTD (CH) | 2012-07-26 | — | — | WO | disclosed |
| WO-2012097511-A1 | DMP-266 BY CYCLISATION | LONZA LTD (CH) | 2012-07-26 | — | — | WO | disclosed |
| EP-2447255-A1 | Process for the synthesis of cyclic carbamates | Lonza Ltd. (CH) | 2012-05-02 | — | — | EP | disclosed |
| EP-2447247-A1 | Process for the synthesis of chiral propargylic alcohols | Lonza Ltd. (CH) | 2012-05-02 | — | — | EP | disclosed |
| WO-2012048886-A1 | PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES | LONZA LTD (CH) | 2012-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160326101-A1 | Process for the Synthesis of Chiral Propargylic Alcohols | ADH1C, ADH1A, ADH5 | CYP2D6 622/4885KCNH2 3738/4885CYP1A2 112/4885 |
| US-20130217875-A1 | PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES | PLCG2, PLCG1, CPS1 | CYP2D6 723/4885KCNH2 1603/4885CYP1A2 640/4885 |
| US-20130324763-A1 | PROCESS FOR THE SYNTHESIS OF CHIRAL PROPARGYLIC ALCOHOLS | ADH1C, ADH1A, ADH5 | CYP2D6 622/4885KCNH2 3738/4885CYP1A2 112/4885 |
| US-20130211077-A1 | PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES | PLCG2, PLCG1, PLCB1 | CYP2D6 949/4885KCNH2 1263/4885CYP1A2 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.